GSK Avandamet Antidiabetic Combo Expected In Pharmacies In November
GlaxoSmithKline's Avandamet combination rosiglitazone/metformin product for diabetes is expected to be available in November, the company said after Oct. 10 FDA approval
GlaxoSmithKline's Avandamet combination rosiglitazone/metformin product for diabetes is expected to be available in November, the company said after Oct. 10 FDA approval